Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rhiannon N Hardwick

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Current Protocols in Toxicology|May 3, 2012
Measuring altered disposition of xenobiotics in experimental models of liver diseaseRhiannon N Hardwick, Nathan J Cherrington
Stem Cell Reports|September 15, 2021
Challenging the pipelinePeter Loskill, Rhiannon N Hardwick, Adrian Roth
Annual Review of Pharmacology and Toxicology|October 29, 2013
Role of hepatic efflux transporters in regulating systemic and hepatocyte exposure to xenobioticsNathan D Pfeifer, Rhiannon N Hardwick, Kim L R Brouwer
Liver International : Official Journal of the International Association for the Study of the Liver|January 19, 2017
Impaired N-linked glycosylation of uptake and efflux transporters in human non-alcoholic fatty liver diseaseJohn D Clarke, Petr Novak, April D Lake, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 25, 2011
Molecular mechanism of altered ezetimibe disposition in nonalcoholic steatohepatitisRhiannon N Hardwick, Craig D Fisher, Stephanie M Street, et al.
Toxicology and Applied Pharmacology|February 23, 2019
Folate receptor-beta expression as a diagnostic target in human & rodent nonalcoholic steatohepatitisApril D Lake, Rhiannon N Hardwick, Christopher P Leamon, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 2011
Variations in ATP-binding cassette transporter regulation during the progression of human nonalcoholic fatty liver diseaseRhiannon N Hardwick, Craig D Fisher, Mark J Canet, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 2010
Diversity in antioxidant response enzymes in progressive stages of human nonalcoholic fatty liver diseaseRhiannon N Hardwick, Craig D Fisher, Mark J Canet, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 10, 2014
Experimental nonalcoholic steatohepatitis increases exposure to simvastatin hydroxy acid by decreasing hepatic organic anion transporting polypeptide expressionJohn D Clarke, Rhiannon N Hardwick, April D Lake, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 2, 2013
Hepatic basolateral efflux contributes significantly to rosuvastatin disposition II: characterization of hepatic elimination by basolateral, biliary, and metabolic clearance pathways in rat isolated perfused liverNathan D Pfeifer, Arlene S Bridges, Brian C Ferslew, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Current Protocols in Toxicology|May 3, 2012
Measuring altered disposition of xenobiotics in experimental models of liver diseaseRhiannon N Hardwick, Nathan J Cherrington
Stem Cell Reports|September 15, 2021
Challenging the pipelinePeter Loskill, Rhiannon N Hardwick, Adrian Roth
Annual Review of Pharmacology and Toxicology|October 29, 2013
Role of hepatic efflux transporters in regulating systemic and hepatocyte exposure to xenobioticsNathan D Pfeifer, Rhiannon N Hardwick, Kim L R Brouwer
Liver International : Official Journal of the International Association for the Study of the Liver|January 19, 2017
Impaired N-linked glycosylation of uptake and efflux transporters in human non-alcoholic fatty liver diseaseJohn D Clarke, Petr Novak, April D Lake, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 25, 2011
Molecular mechanism of altered ezetimibe disposition in nonalcoholic steatohepatitisRhiannon N Hardwick, Craig D Fisher, Stephanie M Street, et al.
Toxicology and Applied Pharmacology|February 23, 2019
Folate receptor-beta expression as a diagnostic target in human & rodent nonalcoholic steatohepatitisApril D Lake, Rhiannon N Hardwick, Christopher P Leamon, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 2011
Variations in ATP-binding cassette transporter regulation during the progression of human nonalcoholic fatty liver diseaseRhiannon N Hardwick, Craig D Fisher, Mark J Canet, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 2010
Diversity in antioxidant response enzymes in progressive stages of human nonalcoholic fatty liver diseaseRhiannon N Hardwick, Craig D Fisher, Mark J Canet, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 10, 2014
Experimental nonalcoholic steatohepatitis increases exposure to simvastatin hydroxy acid by decreasing hepatic organic anion transporting polypeptide expressionJohn D Clarke, Rhiannon N Hardwick, April D Lake, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 2, 2013
Hepatic basolateral efflux contributes significantly to rosuvastatin disposition II: characterization of hepatic elimination by basolateral, biliary, and metabolic clearance pathways in rat isolated perfused liverNathan D Pfeifer, Arlene S Bridges, Brian C Ferslew, et al.
Pageof 4